VR Intervention for Pain

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
UC Irvine Gottschalk Medical Plaza, Irvine, CA
Pain+1 More
Soothe VR - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The study team aims to investigate whether implementing virtual reality therapy (VRT) during Genicular nerve radiofrequency ablation (GNRFA) procedure will provide better alleviation of procedural pain and augmented satisfaction for patients.

Eligible Conditions

  • Pain
  • Satisfaction, Patient

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Pain

Study Objectives

2 Primary · 9 Secondary · Reporting Duration: 2 years

1 year
Subgroup Analysis
2 years
Prior Knee Radiofrequency Ablation
Prior Virtual Reality Use
20 minutes
Additional Local Anesthetic
Pain Thoughts: Duration of Time Patient Spent Thinking of Pain
Patient Procedural Anxiety
Patient Satisfaction with VR Device
Peak Pain During Procedure
Provider Pain Perception of Patient's Pain
Provider Satisfaction During Procedure
Side Effects of Virtual Reality

Trial Safety

Safety Progress

1 of 3

Other trials for Pain

Trial Design

2 Treatment Groups

Control
1 of 2
VR Intervention
1 of 2
Active Control
Experimental Treatment

67 Total Participants · 2 Treatment Groups

Primary Treatment: VR Intervention · No Placebo Group · N/A

VR Intervention
Device
Experimental Group · 1 Intervention: Soothe VR · Intervention Types: Device
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 2 years

Trial Background

Prof. Navid Alem, Associate Clinical Professor
Principal Investigator
University of California, Irvine
Closest Location: UC Irvine Gottschalk Medical Plaza · Irvine, CA
N/AFirst Recorded Clinical Trial
1 TrialsResearching Pain
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You must be aged 18 or older.\n
Patients who have previously received nerve blocks or radiofrequency ablation procedures may be included.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References